Inside informationEnglish
Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 14/11/2025, 12:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118898_20251114